SCHEMBL5884384

SCHEMBL5884384

CCc1nc(C2CCC(OC)CC2)n2nc(-c3ccccc3)[nH]c(=O)c12

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 11/20 0.48
PDE1A P54750 6/20 0.48
PDE1B Q01064 6/20 0.48
PDE1C Q14123 6/20 0.48
KHK P50053 2/20 0.37
GUSB P08236 1/20 0.36
KMT2A Q03164 1/20 0.36
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
TNKS O95271 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
PARP2 Q9UGN5 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5883995 0.93 PDE5A (0.49) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5883663 0.89 PDE5A (0.46) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5883819 0.89 PDE5A (0.46) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5884365 0.89 PDE5A (0.52) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5884355 0.89 PDE5A (0.55) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5884302 0.89 PDE5A (0.46) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5884385 0.88 PDE5A (0.46) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5884416 0.88 PDE5A (0.54) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5883869 0.88 PDE5A (0.54) PDE5APDE1APDE1BPDE1CKHK
SCHEMBL5883988 0.87 KHK (0.49) PDE5APDE1APDE1BPDE1CKHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087605-B2 5-Ethyl-imidazotriazinones BAYER AKTIENGESELLSCHAFT (DE) 2006-08-08 US disclosed
EP-1397363-B1 5-ETHYL-IMIDAZOTRIAZINONES BAYER HEALTHCARE AG (DE) 2005-05-11 EP disclosed
US-20040254187-A1 5-ethyl-imidazotriazinones BAYER HEALTHCARE AG (DE) 2004-12-16 US disclosed
EP-1397363-A1 5-ETHYL-IMIDAZOTRIAZINONES Bayer HealthCare AG (DE) 2004-03-17 EP disclosed
WO-2002098880-A1 5-ETHYL-IMIDAZOTRIAZINONES BAYER HEALTHCARE AG (DE) 2002-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254187-A1 5-ethyl-imidazotriazinones EPX, TPMT, IL5 PDE5A 409/4885PDE1A 860/4885PDE1B 1362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.